Evidence map›Paper›PMID 32066441›Full record

Trial reportBMC medical genomics2020

Pathway mapping of leukocyte transcriptome in influenza patients reveals distinct pathogenic mechanisms associated with progression to severe infection.

Yoann Zerbib, Emily K Jenkins, Maryam Shojaei, Adrienne F A Meyers, John Ho, T Blake Ball, Yoav Keynan, Amarnath Pisipati, Aseem Kumar, Anand Kumar and 5 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in BMC medical genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Immune Responses to Influenza Infection in Children.Open forum infectious diseases · 2026
    Article
  3. Article
  4. PDLIM2 Repression: A Common Mechanism in Viral Lung Infection.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cycling and activated CD8BMC immunology · 2022
    Article
  13. Article
  14. Article
  15. Frontiers in immunology · 2022
    Observational
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Yoann ZerbibDepartment of medical Intensive Care, Amiens University Hospital, Amiens, France. zerbib.yoann@chu-amiens.fr.
Emily K JenkinsDepartment of Intensive Care Medicine, Nepean Hospital, Sydney, Australia.
Maryam ShojaeiDepartment of Intensive Care Medicine, Nepean Hospital, Sydney, Australia.
Adrienne F A MeyersNational HIV and Retrovirology Laboratories, JC Wilt infectious disease research centre, Public health agency of Canada, Winnipeg, Canada.
John HoNational HIV and Retrovirology Laboratories, JC Wilt infectious disease research centre, Public health agency of Canada, Winnipeg, Canada.
T Blake BallNational HIV and Retrovirology Laboratories, JC Wilt infectious disease research centre, Public health agency of Canada, Winnipeg, Canada.
Yoav KeynanDepartment of internal medicine, medical microbiology and community health sciences, University of Manitoba, Winnipeg, Canada.
Amarnath PisipatiDepartment of medical microbiology and infectious diseases, University of Manitoba, Winnipeg, Canada.
Aseem KumarDepartment of chemistry and biochemistry, Laurentian University, Sudbury, Canada.
Anand KumarSection of critical care medicine and section of infectious diseases, department of medicine, medical microbiology and pharmacology, University of Manitoba, Winnipeg, Canada.
Marek NalosDepartment of Intensive Care Medicine, Nepean Hospital, Sydney, Australia.
Benjamin M TangDepartment of Intensive Care Medicine, Nepean Hospital, Sydney, Australia.
Klaus SchughartDepartment of Infection Genetics, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Anthony McLeanDepartment of Intensive Care Medicine, Nepean Hospital, Sydney, Australia.
Nepean Genomic Research Group
University of Manitoba · CANepean Hospital · AUCentre Hospitalier Universitaire Amiens-Picardie · FRUniversity of Veterinary Medicine Hannover, Foundation · DEWestmead Institute for Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfluenza infections produce a spectrum of disease severity, ranging from a mild respiratory illness to respiratory failure and death. The host-response pathways associated with the progression to severe influenza disease are not well understood.

methodsTo gain insight into the disease mechanisms associated with progression to severe infection, we analyzed the leukocyte transcriptome in severe and moderate influenza patients and healthy control subjects. Pathway analysis on differentially expressed genes was performed using a topology-based pathway analysis tool that takes into account the interaction between multiple cellular pathways. The pathway profiles between moderate and severe influenza were then compared to delineate the biological mechanisms underpinning the progression from moderate to severe influenza.

results107 patients (44 severe and 63 moderate influenza patients) and 52 healthy control subjects were included in the study. Severe influenza was associated with upregulation in several neutrophil-related pathways, including pathways involved in neutrophil differentiation, migration, degranulation and neutrophil extracellular trap (NET) formation. The degree of upregulation in neutrophil-related pathways were significantly higher in severely infected patients compared to moderately infected patients. Severe influenza was also associated with downregulation in immune response pathways, including pathways involved in antigen presentation such as CD4+ T-cell co-stimulation, CD8+ T cell and Natural Killer (NK) cells effector functions. Apoptosis pathways were also downregulated in severe influenza patients compare to moderate and healthy controls.

conclusionsThese findings showed that there are changes in gene expression profile that may highlight distinct pathogenic mechanisms associated with progression from moderate to severe influenza infection.

Indexed as

Gene Expression RegulationTranscriptomeAdultAgedFemaleHumansInfluenza, HumanLeukocytesMaleMiddle AgedSeverity of Illness IndexInfluenzaNeutrophil extracellular trapNeutrophilsTranscriptome

Identifiers

PMID32066441
PMCPMC7027223
OpenAlexW3009917904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.